title: [Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Pro].
authors.affiliation: Klinik für Neurologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland, sven.meuth@ukmuenster.de.
authors.forename: S G
authors.initials: SG
authors.lastname: Meuth
mesh_terms: D000284:Administration, Oral; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents